Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Millward Brown

Novartis building

Novartis offloads diagnostics unit to Grifols for $1.7bn

Part of strategy to focus on more profitable businesses

- PMLiVE

Salix boosts GI portfolio with $2.6bn deal for Santarus

Will reduce company’s reliance on diarrhoea treatment Xifaxan

- PMLiVE

Profits down at Lundbeck as revenues slip

Company still feeling effects of Lexapro patent loss

- PMLiVE

Endo agrees $1.6bn deal to buy Paladin Labs

Gives company access to Canada and emerging markets

- PMLiVE

Publicis adds Heartbeat to portfolio

Digital agency will merge with Saatchi Health agencies in the US

Roche - Basel

Roche signs €400m superbug deal

Buys rights to investigational antibiotic from Polyphor

- PMLiVE

Novo enrols first patient in Tresiba cardiovascular trial

Milestone comes as diabetes-focused company reports solid growth

Bayer symbol

Bayer buoyant as new products drive pharma

Xarelto, Stivarga, Eylea and Xofigo all perform will in third quarter

Sanofi reception

Sanofi returns to growth in Q3

Diabetes products and Genzyme help company overcome patent cliff

- PMLiVE

Pfizer sales down but oncology shows promise

Toll of patent expiries continues

Biogen Idec building

Rocketing Tecfidera sales give Biogen Idec stellar Q3 results

Oral MS drug on course for blockbuster status in first year

Bristol-Myers Squibb (BMS) building

BMS bounces back to form in Q3

New launches in cancer, diabetes and RA help recovery from patent expiries

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links